A study to evaluate long-term safety and efficacy in patients with type-2 diabetes mellitus who had inadequate glycemic control with liraglutide
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 18 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association